706 POSTER A phase I dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly and twice weekly erlotinib in advanced stage solid malignancies
暂无分享,去创建一个
K. Gelmon | S. Chia | C. Kollmannsberger | K. Chi | S. D'Aloisio | E. Zwanziger | H. Kletzl | K. Paton | A. Das-Gupta | K. Bhagat